Flagship Pioneering, LLC

Q3 2022 13F Holdings Report, Stock Holdings

Notable people
Ph.D. Noubar B. Afeyan
Signature - Title
Noubar B. Afeyan, Ph.D. - Chief Executive Officer
Location
Cambridge, MA
Holdings as of
30 Sep 2022
Value $
$2,375,805,000
Num holdings
12
Filing time
14 Nov 2022, 16:00:29 UTC
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included MRNA, SANA, MCRB, OMGA, and FHTX.
Previous filing
Q2 2022 - 15 Aug 2022
Next filing
Q4 2022 - 14 Feb 2023
SEC
View on sec.gov
Sym Weight Trade Impact Company Class Share Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2022 Q3 compared to 2022 Q2 by default. Changes are calculated vs the previous SEC filing.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Noubar B. Afeyan, Ph.D. Chief Executive Officer Cambridge, Massachusetts 14 Nov 2022

Other Included Managers (7):

Num Name Location File Number
1 Flagship Ventures Fund V General Partner LLC Cambridge, MA 028-18466
2 Flagship Ventures Fund IV General Partner LLC Cambridge, MA 028-17238
3 Ph.D. Noubar B. Afeyan Cambridge, MA 028-19988
4 Flagship Ventures Opportunities Fund I General Partner LLC Cambridge, MA 028-20999
5 Flagship Pioneering Special Opportunities Fund II General Partner LLC Cambridge, MA 028-20997
6 Nutritional Health LTP Fund General Partner LLC Cambridge, MA 028-21001
7 Flagship Pioneering Fund VI General Partner LLC Cambridge, MA 028-20998